AcelRx Pharma (NASDAQ: ACRX) reported Q1 EPS of ($0.23), versus ($0.34) reported last year. Revenue for the quarter came in at $343 million, versus $3.11 billion reported last year.

For earnings history and earnings-related data on AcelRx Pharma (ACRX) click here.